Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. Codiak BioSciences was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Codiak Biosciences Inc market cap is $58,927.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Codiak Biosciences Inc 52 week high is $3.23 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Codiak Biosciences Inc 52 week low is $0.0016 as of November 17, 2026.
Codiak Biosciences Inc stock price today is $0.0016.
Codiak Biosciences Inc stock price yesterday was $0.0085.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Codiak Biosciences Inc P/B ratio is 0.0015.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Codiak Biosciences Inc 50-day moving average is $0.0103.